Press Release

NYU Langone Health Ranks No. 1 in New York STATE and No. 3 in the Nation No 1. Neurology and Neurosurgery Program in the Country

July 26th 2022

Neurology and Neurosurgery at NYU Langone Rank No. 1 in Nation

July 26th 2022

NeurologyLive® Announces Giants of Multiple Sclerosis™ Inaugural Class of Inductees

June 3rd 2022

Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights

FDA Clears Roche’s Elecsys pTau181 Test for Ruling Out Alzheimer-Related related Amyloid Pathology

Trofinetide Leads to Real-World Improvements in Rett Syndrome Symptoms, LOTUS Study Finds

Understanding Ocrelizumab’s Impact on Advanced Progressive MS: Insights From Dr. Gavin Giovannoni

FDA Delays Review Deadline for Hunter Syndrome Agent Tividenofusp Alfa

Overviewing Phase 3 OPERETTA 2 Trial and Ocrelizumab’s Impact on Pediatric Multiple Sclerosis: Brenda Banwell, MD, FRCPC, FAAN

© 2025 MJH Life Sciences^®

All rights reserved.